Search
Now showing items 1-10 of 12
Budd-Chiari syndrome in association with Behçet's disease: review of the literature
(Associação Paulista de Medicina - APM, 2011)
The risk that patients with Behçet's disease may develop various thrombotic complications has been previously described. Although vascular complications from Budd-Chiari syndrome associated with Behçet's disease have been ...
Long-Term Follow-Up After Successful Transjugular Intrahepatic Portosystemic Shunt Placement in a Pediatric Patient with Budd-Chiari Syndrome
(SPRINGER, 2008)
Orthotopic liver transplantation is the standard of care in patients with Budd-Chiari syndrome (BCS), and transjugular intrahepatic portosystemic shunt (TIPS) has become an important adjunct procedure while the patient is ...
Budd-Chiari syndrome in a 25-year-old woman with Behçet's disease: a case report and review of the literature
(2011)
Abstract
Introduction
The risk that patients with Behçet's disease will develop thrombotic complications has been previously described. Although it is distributed worldwide, Behçet's disease is rare in the Americas and ...
Hepatic Veins and Inferior Vena Cava Thrombosis in a Child Treated by Transjugular Intrahepatic Portosystemic Shunt
(SPRINGER, 2010)
We report the case of a 9-year-old boy with portal hypertension, due to Budd-Chiari syndrome, and retrohepatic inferior vena cava thrombosis, submitted to a transjugular intrahepatic portosystemic shunt (TIPS) by connecting ...
Fulminant hepatic failure Insuficiencia hepática fulminante
(2002)
Fulminant hepatic failure (FHF) is an acute and eventually fatal illness, caused by a severe hepatocyte damage with massive necrosis. Its hallmarks are hepatic encephalopathy and a prolonged prothrombin time (<40%). FHF ...
Behçet's Disease: Symptoms, Diagnosis And Treatment
(Nova Science Publishers, Inc., 2011)
Fibrolamellar Hepatocellular Carcinoma and Noncirrhotic Hyperammonemic Encephalopathy
(Universidad del RosarioEspecialización en GastroenterologíaFacultad de Medicina, 2018)
Fibrolamellar hepatocarcinoma is an infrequent liver tumor, currently considered to be a variant different from hepatocarcinoma. The differences lie in genomic alterations, a greater prevalence of fibrolamellar hepatocarcinoma ...